Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

PhotoMedex Concludes Acculase Acquisition
Sep 2000
RADNOR, Pa., Sept. 1 -- PhotoMedex Inc. has reached an agreement to obtain the remaining 23.9 percent of Acculase Inc.'s shares in return for 300,000 common shares of PhotoMedex. Once the agreement is finalized Acculase will become a wholly owned subsidiary of PhotoMedex.
We are pleased to have reached this agreement with the minority shareholders of Acculase, and now will continue to focus on advancing the initiatives of our beta sites and the roll-out of our Phase 2 commercial launch of the XTRAC laser system for the treatment of psoriasis, utilizing the key technology and patents developed at Acculase, said Jeff O'Donnell, president and CEO of PhotoMedex.
PhotoMedex is a developer of proprietary excimer laser and fiber-optic systems for treatment of cardiovascular and vascular disease and for dermatological applications such as psoriasis. The basis of the company's business is its excimer laser technology.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.